INTRODUCTION
Lyme disease, a seasonal inflammatory disorder, has been reported from the United States, Europe, and Australia (1) (2) (3) (4) . In the United States, most patients Received for publication 26 November 1982 and in revised form 20 April 1983. have acquired the disease during the summer in areas along the northeastern seaboard, in Wisconsin and Minnesota, or in Oregon and California (5, 6) . The most specific manifestation of Lyme disease is erythema chronicum migrans (ECM),' an expanding annular skin lesion accompanied by fever, headache, and myalgias (7, 8) . In a typical Lyme disease case, the initial ECM lesion is followed, after an interval lasting a few days or a few months, by involvement of the joints, nervous system, and/or heart (8) . The arthritis in its early phase is most commonly pauciarticular and relapsing; in some patients, it may progress to a chronic arthritis that has the histologic characteristics of rheumatoid arthritis (9) . The nervous system involvement is usually characterized by a meningoencephalitis, cranial neuritis, and/or radiculoneuritis that are fluctuating in degree (10) . A minority of patients may also, or instead, develop high degree heart block (11) . In general, the arthritic complications appear later and last longer than the neurologic and cardiac sequelae (8) .
The seasonality of the disorder (1, 5, 6) , the clustering of cases (1) , the apparent transmission of ECM via inoculations of skin lesion samples (12) , and the amelioration of Lyme disease with antibiotics (13) have suggested an infectious etiology. There is evidence, however, that the host's immune response to the infectious agent may also be important in the pathogenesis of Lyme disease. The majority of acutely ill patients have circulating immune complexes and cryoglobulins (14, 15) , and the neurologic and cardiac manifestations resemble those of serum sickness and rheumatic fever, respectively (10, 11) .
The association of Lyme disease with a preceding ixodid tick bite or with residence in an area with a high density of ixodid ticks has been established (5, 16, 17) . We have previously proposed that a hitherto unknown spirochete, which was isolated from the ixodid tick Ixodes dammini, is the etiologic agent of Lyme disease (18) . Subsequent isolations of similar, if not identical, spirochetes from Lyme disease patients support this proposal (19, 20) . In addition, we found that rabbits fed upon by spirochete-infected I. dammini ticks developed ECM-like skin lesions (18, 21) .
In the present study, we addressed the following questions: (a) Against what components of the I. dammini spirochete (IDS) do Lyme disease patients have antibodies? (b) Are elevated concentrations of antibodies to IDS components specific for Lyme disease patients? (c) Are the antibody responses of Lyme disease patients specific for IDS components? METHODS Strains and culture conditions. The I. dammini spirochete strain B31, originally isolated from ticks collected on Shelter Island, NY (18) , was cloned by limiting dilution and then passaged in Barbour, Stoenner, Kelly (BSK) medium, a modification of fortified Kelly's medium (18, 22, 23) . Batch cultures of B31 were made in glass tissue culture bottles (Gibco Laboratories, Grand Island, NY) that had been rinsed with glass-distilled water, autoclaved, and filled with 533 ml of warm BSK medium. Each bottle was inoculated with 8 ml of a late log-phase culture, tightly capped, and incubated at 350C for 4-5 d. The final density of organisms was 0.5-1.0 X 108/ml. The cells were harvested by centrifugation (10, Table II summarizes the remainder of control sera; the residence, if known, of persons from whom blood was drawn; the illness, if any, of these persons; and the source of the sera, if other than one of the authors.
Adult New Zealand white rabbits that had been fed upon by spirochete-infected I. dammini ticks and that had subsequently developed ECM-like skin lesions (18, 21) were bled 10-12 wk after the tick feedings.
Indirect immunofluorescence assay (IFA). Human sera were examined for antibodies against methanol-fixed B31 organisms by IFA, as described (24) . The fluorescinated goat anti-human globulin serum (BBL Microbiology Systems, Becton-Dickinson and Co., Cockeysville, MD) was used in a 1:200 dilution of 1% bovine serum albumin (BSA) in PBS. The criterion for a positive reaction was fluorescence of spirochetes that was greater than the background staining of rat erythrocytes on the smear. The presence or absence of fluorescent blebs on the spirochetes was also noted during the assays.
Polyacrylamide gel electrophoresis (PAGE). Frozen spirochetes were thawed, centrifuged for 3 min in a microfuge (Beckman Instruments, Inc., Irvine, CA), and washed three times with cold PBS/Mg. After the last centrifugation, cells were suspended in a volume of distilled water to give an OD595 of 0.2 when the cell suspension was analyzed for protein content by the Bradford method (25) . Sample buffer was added to the cells in water for final concentrations of 1% sodium dodecyl sulfate (SDS; British Drug Houses, Ltd., Poole, Dorset, England) and 10% 2-mercaptoethanol. The samples were boiled for 5 min, and 25 Il (-15 jAg of protein) was subjected to SDS-PAGE as described by Laemmli and Favre (26) . The pH of the separating gel buffer was 8.6, and the acrylamide concentration was 10%. Tris base was obtained from Research Organics, Inc., Cleveland, OH. Gels were stained with Coomassie Brilliant Blue R-250 or by the silver stain method of Switzer et al. (27) as modified by P. J. Hitchcock and T. M. Brown (paper submitted for publication). Molecular weight standards labeled with 14C were phosphorylase B (93,000), bovine albumin (69,000), ovalbumin (46,000), carbonic anhydrase (30, 000) , and beta lactoglobulin (18,000) (New England Nuclear, Boston, MA).
Labeling of spirochetes with radioactive iodine. Washed and thawed spirochetes were labeled with 125I in the presence of 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril (lodogen; Pierce Chemical Co., Rockford, IL) by a modification of the method of Markwell and Fox (28) . The modification has been described (24) . The spirochetes were in a suspension in PBS/ Mg that had a protein content of 0.3 mg/ml by the Bradford assay (25) . The labeled preparations were examined by SDS-PAGE as described above. The gels were dried and radioautography was performed on the dried gels with Kodak XOmat AR or TL film (Eastman Kodak Co., Rochester, NY).
Electrophoretic transfer of separated proteins from SDS-PAGE to nitrocellulose (NC) and application of antibody to the blots. The procedure used for performing transfer of proteins from SDS-PAGE gels to NC and incubation of blots with sera (western blot) was a modification of the methods of Towbin et al. (29) and Renart et al. (30) . The proteins in a gel were transferred to NC (HAHY; Millipore Corp., Bedford, MA) in a Trans-Blot cell (Bio-Rad Laboratories, Richmond, CA) containing 192 mM glycine, 26 mM Tris base, and 20% methanol. The cell was kept at 25°C with a cooling coil during electrophoresis (60 V for 3 h). After electrophoresis, the NC blots were blocked by overnight incubation in heat-sealable plastic bags containing 2% BSA (fraction V; Miles Laboratories, Elkhart, IN) in 50 mM Tris (pH 7.4), 150 mM NaCl, 5 mM EDTA, 0.25% gelatin (Knox Gelatine, Inc., Englewood Cliffs, NJ), 0.05% sodium azide, and 0.05% Nonidet P-40 (TSGAN) (31) . We incubated the blots in plastic tubes containing a 1:100 dilution of human or rabbit sera in 2% BSA/TSGAN for 2 h at room temperature. The strips were then washed three times with TSGAN. The blots were incubated with '25I-labeled protein A (5 X 105 cpm/ml TSGAN) for 1 h at room temperature. Protein A (Pharmacia Fine Chemicals, Division of Pharmacia Inc., Piscataway, NJ) had been labeled by a modification of the chloramine-T method of Hunter and Greenwood (32) to a specific activity of 5 ,uCi/ug. The blots were washed four times with TSGAN, rinsed several times with water, dried, and placed on X-ray film. AR and TL films were exposed for 14-24 h and 2-4 d, respectively.
Solid phase radioimmunoassay (RIA). Thawed and washed spirochetes were lysed in 0.1% SDS in 50 mM sodium phosphate buffer, pH 6.2. The suspension was centrifuged (51,000 g for 60 min at 20°C). The supernatant volume was adjusted with 0.1% SDS in the phosphate buffer to give a protein content of 0.2 mg/ml by the Bradford assay (25) . The lysyl, tyrosyl, and histidinyl residues of proteins in the solution were reacted with diazonium groups on diazophenylthioether (DPT) paper that was prepared by the method attributed to B. Seed (33) . Whatman 540 paper (Whatman Inc., Clifton, NJ) was the cellulose substrate for activation. The activated paper was reacted with the lysate solution for 3 h at 21°C in heat-sealable bags on a rocker. The remaining diazonium groups were blocked by incubation of the paper with 100 mM Tris, pH 9.0, 10% ethanolamine, and 0.25% gelatin (30) overnight at room temperature. The paper was then washed several times with water and dried. With a paper punch, we cut 6.4-mm diameter disks from the paper and stored them in a desiccator at 4°C for up to 4 mo before use. Before the 0.1% SDS-soluble proteins of 125I-labeled IDS (see above) in the reaction mixture, we estimated in preliminary studies that each disk had 150 ng of IDS protein that was not removed by several washes with 2% SDS.
At the time of the assay, disks were placed in a flat bottom, 96-well, polystyrene microliter plate (Linbro, Falcon Plastics, Oxnard, CA) and covered with 2% BSA/TSGAN for 30 min. After aspiration of this solution, twofold dilutions of human or rabbit sera in 2% BSA/TSGAN in 100-pu volumes were placed in wells. The plates were incubated for 60 min at 37°C. The solutions were aspirated, and the wells were washed three times with TSGAN. '251-labeled protein A in TSGAN was incubated with the disks ( western blot could be identified as B31 lysate components. We then examined sera from other patients with Lyme disease (Fig. 2) and sera from controls (Fig. 3) material that did not leave the stacking gel (location tations and had been followed for months to years after shown by arrows in Fig. 2) . The remaining patients, onset of their diseases, had IgG antibodies that bound all of whom had neurologic and/or arthritic manifes-to one or more B31 components. The solid triangle in Fig. 2 (patients B, C , and E-K) was performed. All patients had antibody that bound to components 5 and 6. 25 (93%) of the 27 sera also contained IgG that bound components 8 and 10. Only 12 (37%) of the patients had detectable antibody to component 4, a protein that was abundant in whole cell lysates but was poorly labeled with iodine ( Fig. 1) .
We also compared the reactions of Lyme disease patient sera in blots to those of rabbits that had been fed upon by infected I. dammini ticks and who had subsequently developed skin lesions that resembled ECM. Blots using sera from three of these rabbits (3050, 3092, and 3093) and serum from control rabbit who had been fed upon by Dermacentor variabilis ticks are shown in Fig. 4 . Although the rabbits had antibodies to components that were not generally recognized by human sera, many of the 10 components were recognized by the rabbits with ECM-like lesions. The D. variabilis control rabbit serum shown in the figure, as well as other control rabbit sera not shown, did not contain IgG that detectably bound to any IDS component.
Because of the possibility that Lyme disease patients had elevated antibodies against IDS components in western blots as a result of polyclonal B cell stimulation, we examined the reactivity of serum H3 to components of several other bacteria. These include P. aeruginosa, R. rickettsii, T. phagedenis, L. interrogans, B. hermsii, C. psittaci, and E. coli. In Fig. 5 , the panel on the left shows the Coomassie Blue-stained proteins in SDS lysates of these bacteria. The panels in the middle and on the right are the radioautographs of blots using sera H1 and H3 and serum from control 6 Control 6 had detectable antibodies to components of P. aeruginosa, R. rickettsii, C. psittaci, and E. coli. Similar, relatively weak reactivities to components of these bacteria were shown by other control sera that were examined.
Solid-phase RIA. A solid phase RIA was designed to quantitatively estimate the IgG response to SDSextractable proteins that had been qualitatively demonstrated by western blot analysis. The presumed advantage of DPT paper for a RIA was that, in contrast to NC, proteins could be covalently bound to the solidphase matrix and bound in the presence of SDS (30, 33, 35) . When selected Lyme disease and control sera were examined in this way, we found that the Lyme disease patients had elevated titers (Tables I and II) .
The titers rose between early and later serum samples. Controls who had elevated IFA titers or who had some anti-IDS component antibodies by western blot analysis were negative by the criteria described. We also calculated, for a serum dilution of 1:160, the net radioactivity associated with the IDS disks, i.e., the counts per minute for the IDS disks minus counts per minute for the blank disks. The mean counts per minute±SE for patient sera C2, E3, F3, H3, and J4 in the assays was 4,741±1,360. The mean counts per minute±SE for control sera _ . , . *>s mg-u-m. FIGURE 3 Western blot analysis of control sera 1-41 (Table II) . Methods described in text and in legend of Fig. 1 . The numbers correspond to similarly migrating IDS components identified in Fig. 1 (19, 20) and the evolution of IgM and IgG antibody responses during the course of Lyme disease (19, 20 , present study) does indicate that an IDS-like spirochete infection is contemporaneous with Lyme disease.
Other examples of antigenic cross-reactivities between a treponeme, a borrelia, a leptospire, and the IDS were seen in Fig. 5 . In the same figure are generally fainter bands in PAGE lanes containing more distantly related bacterial genera, such as Pseudomonas and Rickettsia. Although we cannot rule out nonimmune binding or sticking of IgG molecules in patient H's and control 6's sera to these bacterial components, we suspect that these persons probably did have immunoglobulins that bound to these components via antigen-recognition sites. These antibodies, which were apparently in lower concentration and/or of lower affinity compared to the anti-IDS antibodies of patient H, may have resulted from remote infections or colonizations with these or related species. Alternatively, they may result from spontaneous or background immunoglobulin synthesis (38) . In any case, the sensitivity of western blot analysis appears to necessitate use of antigen controls, such as the distantly related bacteria used in this study, as well as serum controls.
We identified several other IDS components against which Lyme disease patients had antibodies. Additional to components that entered the separating gel was the material that did not leave or may not have even entered the stacking gel. The nature of this apparently SDS-insoluble material, against which some patients with Lyme disease and patients with syphilis had antibody, is unknown. It is possible that it is spirochetal peptidoglycan, a material that would not enter the gel. 
